Atrial Fibrillation Flashcards
Presentation of AF
Often asymptomatic but can present with: Fast irregular HR dizziness syncope chest pain SOB
or with symptoms of associated conditions:
strokes
thyrotoxicosis
sepsis
Types of AF
Precipitants for AF
- Valvular - moderate-severe MR or mechanical heart valve
- Non-valvular
SMITH S = sepsis M = mitral valve pathology I = =IHD T = thyrotoxicosis H = HTN
\+ age surgery, sleep apnea, smoking alcohol PE CKD, DM, male, Obesity
Differential for irregulary irregular pulse
AF
Ventricular ectopics
complete heart block with variable ventricular escape
A. Flutter
-distinguished from each other by ECG with ventricular ectopics disappearing when heart rate increases
Investigations to enquire about
ECG
ETT
ECHO
Bloods - TFT, UEC, Trops
2 principals of management
- rate/rhythm control
2. anticoagulation
Acute management:
1st line is rate control unless there is the following:
- < 48h since clear onset
- reversible cause
- AF is causing HF or haemodynamically unstable
- symptomatic despite being rate controlled
In which case pharm cardioversion - flecainide or amiodarone infusion or DC cardioversion (immediate or delayed) can be used to rhythm control
Rate control using
- Bisoprolol or atenalol (not in acute HF)
- Diltiazem
- Digoxin (only in sedentary people and check levels as can cause N+V, neuro impacts)
Thromboprophylaxis/Anti-coagulation
- 1st line is dabigitran (or rivaroxiban)
- 2nd line is warfarin with LMWH (enoxaparin) used to bridge until warfarin is at therapeutic level (INR 2-3)
Chronic Management:
- Continued rate control
- Rhythm control post medical or DC cardioversion either done acutely or after 3 weeks of anticoagulant
Amiodarone = no exclusions but check TFT, LFT, PFT
Sotalol = not if EF < 35%
Flecainide = not if structural defect, only AF
“pill in the pocket” for PAF with flecainide or sotalol
- NOT IF A. FLUTTER
Antiocoagulation? the decision
Without anticoagulation their risk is about 5% per year depending on score. With meds it drops to about 1-2% so small absolute but 2/3 relative reduction.
Puts risk of bleeds at 2-3% when on anticoagulation
CHA2DS2VAS > 1 CHF HTN Age2 >75 DM Stroke 2 Vasc disease Age > 65 Sex - male